Phase I trial of intravenous reovirus and docetaxel in patients with advanced or metastatic solid tumors

Trial Profile

Phase I trial of intravenous reovirus and docetaxel in patients with advanced or metastatic solid tumors

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 29 Nov 2010

At a glance

  • Drugs Docetaxel; Pelareorep
  • Indications Bladder cancer; Breast cancer; Gastrointestinal cancer; Lung cancer; Malignant melanoma; Mesothelioma; Pancreatic cancer; Prostate cancer; Solid tumours; Squamous cell cancer
  • Focus Adverse reactions
  • Sponsors Oncolytics Biotech
  • Most Recent Events

    • 29 Nov 2010 Results were published in Clinical Cancer Research, according to an Oncolytics Biotech media release.
    • 20 Mar 2009 Updated results were presented at the 5th International Meeting on Replicating Oncolytic Virus therapeutics, according to an Oncolytics Biotech media release.
    • 18 Dec 2008 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top